AssetMark Inc’s St Jude Medical STJ Stock Holding History

AssetMark Inc’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,040	Closed	-$83K	–	1459
2016 Q3	$83K	Sell	1,040 -174	-14%	-$14K	﹤0.01%	525
2016 Q2	$95K	Sell	1,214 -42	-3%	-$3K	﹤0.01%	493
2016 Q1	$69K	Buy	1,256 +11	+0.9%	+$599	﹤0.01%	507
2015 Q4	$77K	Buy	+1,245	New	+$78.5K	﹤0.01%	535

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AssetMark Inc's STJ Position: Q4 2016 in Review

AssetMark Inc sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 1,040 shares — an estimated $83K sold.

AssetMark Inc first reported a position in STJ in Q4 2015 and held it in 4 quarters. The position peaked at $95K in Q2 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

AssetMark Inc reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
AssetMark Inc sold 1,040 St Jude Medical shares in Q4 2016, an estimated $83K.
AssetMark Inc first reported a position in St Jude Medical in Q4 2015 and held it in 4 quarters.
AssetMark Inc's St Jude Medical position peaked at $95K in Q2 2016.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on AssetMark Inc's 13F filing for Q4 2016, filed 14 Feb 2017.